Cancer risk among children with very low birth weights

Logan G Spector1, Susan E Puumala, Susan E Carozza

  • 1Division of Epidemiology/Clinical Research, Department of Pediatrics and bMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA. spector@umn.edu

Pediatrics
|July 1, 2009
PubMed

Insights

Most childhood cancers are not linked to low birth weight, except for hepatoblastoma. Very low birth weight may slightly increase risks for certain gliomas and retinoblastomas.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Public Health

Background:

  • Hepatoblastoma risk is elevated in very low birth weight (VLBW) infants.
  • Limited data exist on VLBW and other childhood cancers.

Purpose of the Study:

  • To investigate the association between VLBW and the risk of various childhood cancers.

Main Methods:

  • A large case-control study combined data from five US states.
  • 17,672 children with cancer and 57,966 controls were analyzed.
  • Logistic regression adjusted for multiple demographic and birth factors.

Main Results:

  • No significant association found between VLBW and most childhood cancers.
  • Retinoblastomas and certain gliomas showed a possible association with VLBW.
  • Increased risk of other gliomas observed in moderately low birth weight infants (1500-1999g).

Conclusions:

  • VLBW is not linked to most childhood cancers, reinforcing the known hepatoblastoma association.
  • Potential increased risks for certain gliomas and retinoblastoma warrant further investigation.
Abstract

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...